We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Test for Blood Pressure Meter of CH-101

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01029119
First Posted: December 9, 2009
Last Update Posted: December 9, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Citizen Systems Japan Co., Ltd.
  Purpose
Blood pressure meter model CH-101 was to be assessed against the standard mercury sphygmomanometer according to the protocol of the ANSI/AAMI SP-10.

Condition
Blood Pressure

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Clinical Test of Blood Pressure Meter of CH-101

Further study details as provided by Citizen Systems Japan Co., Ltd.:

Primary Outcome Measures:
  • Measure the accuracy of blood pressure meter model CH-101 assessed against the standard mercury sphygmomanometer according to the protocol of ANSI/AAMi SP-10. [ Time Frame: 30 minutes. ]

Enrollment: 85
Study Start Date: August 2006
Study Completion Date: February 2007
Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   22 Years to 84 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Community sample
Criteria

Inclusion Criteria:

  • 85 subjects with a wide range of blood pressure were selected.

Exclusion Criteria:

  • Subjects could be taking antihypertension medication, but excluded in atrial fibrillation or with any sustained arrhythmia.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01029119


Locations
Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Sponsors and Collaborators
Citizen Systems Japan Co., Ltd.
  More Information

Responsible Party: Makoto Okamoto, Citizen Systems Japan, Co. Ltd.
ClinicalTrials.gov Identifier: NCT01029119     History of Changes
Other Study ID Numbers: Citizen - CH101
First Submitted: December 7, 2009
First Posted: December 9, 2009
Last Update Posted: December 9, 2009
Last Verified: December 2009

Keywords provided by Citizen Systems Japan Co., Ltd.:
blood pressure